HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.
Emergency Medicine
Meta-analysis
Subprophylactic anti-Xa levels linked to higher venous thromboembolism risk in critically ill adults receiving low-molecular-weight heparin
Low blood clot prevention drug levels linked to higher risk in sick adults
A systematic review and meta-analysis of 7,124 critically ill adults reveals that 47% failed to achieve target anti-Xa levels. Subprophylact…
A large review found that nearly half of critically ill adults did not reach safe drug levels. Those with lower levels faced a much higher c…
May 6, 2026
Ophthalmology
FDA Approval
FDA Approves Pavblu (aflibercept) for Neovascular AMD, RVO, DME, and DR
FDA approves Pavblu to treat several eye conditions that cause vision loss.
The FDA approved Pavblu (aflibercept) for neovascular AMD, macular edema following RVO, DME, and DR. It is a VEGF inhibitor administered by …
The FDA approved Pavblu (aflibercept) for wet age-related macular degeneration, macular edema, diabetic macular edema, and diabetic retinopa…
FDA
May 5, 2026
Hematology
Meta-analysis
Systematic review and meta-analysis finds high prevalence of ocular manifestations in leukemia patients
Leukemia patients face eye risks that doctors must spot early now
This systematic review and meta-analysis of 1016 patients with leukemia found a 42% prevalence of overall ocular manifestations.
New data shows almost half of leukemia patients have eye issues, so regular eye checks are essential for better care
May 1, 2026
Ophthalmology
Cohort
COVID-19 pandemic linked to no significant change in retinal vascular occlusion incidence at a Swiss eye hospital
COVID-19 Did Not Raise Eye Stroke Risk, Study Finds
This retrospective cohort study compared retinal vascular occlusion diagnoses in 2019 versus 2020 at a Swiss eye hospital.
New eye data shows COVID’s first year did not raise the risk of retinal vein or artery blockages.
Frontiers
Apr 27, 2026
Oncology
Meta-analysis
Meta-analysis identifies prognostic factors for recurrent VTE and bleeding in 96 753 adult cancer patients
Certain cancer types and health factors raise risk of blood clots or bleeding in adults with cancer and VTE
This meta-analysis evaluated prognostic factors for recurrent venous thromboembolism (VTE) or anticoagulant-related bleeding in 96 753 adult…
A large review found that specific cancers and health factors significantly increase the risk of recurrent blood clots or bleeding in adults…
Apr 23, 2026
Cardiology
Meta-analysis
Systematic review and meta-analysis finds high VTE incidence in stroke patients and moderate model performance
Doctors Rethink How to Spot Blood Clots in Stroke Patients
This systematic review and meta-analysis of seven prediction models found a pooled VTE incidence of 20.8% in stroke patients.
It starts with a small ache in the leg. A little swelling.
Frontiers
Apr 23, 2026
Primary Care & Family Medicine
Meta-analysis
Meta-analysis finds education lowers DVT risk after orthopedic surgery
Teaching patients about DVT cuts risk after orthopedic surgery
This meta-analysis of six studies in orthopedic surgery patients found that education-based interventions were associated with a significant…
A review of studies finds that educating patients about deep vein thrombosis after orthopedic surgery can significantly lower their risk of …
Apr 23, 2026
Oncology
RCT
Inflammatory and cardiac markers linked to VTE and bleeding risks in cancer patients on apixaban
New Blood Tests May Predict Clot and Bleed Risks in Cancer
A post hoc analysis of an RCT in 574 ambulatory cancer patients with a Khorana score ≥2 found that elevated baseline growth differentiation …
Scientists found specific blood markers that signal higher risks of clots and bleeding in cancer patients.
Apr 22, 2026
Cardiology
Meta-analysis
Genetic polymorphisms influence pharmacokinetics and bleeding risk for DOACs in meta-analysis
Your DNA May Explain Why Blood Thinners Work Differently for You
A meta-analysis of 39 studies involving 13,300 patients found that genetic polymorphisms (e.g., CES1, ABCB1) are associated with pharmacokin…
Tiny DNA differences may explain why the same blood thinner protects one person but causes bleeding in another.
Frontiers
Apr 15, 2026
Pediatrics
Meta-analysis
Meta-analysis finds increased VTE risk in pediatric IBD, especially ulcerative colitis
Kids with Bowel Disease Face a Hidden Blood Clot Risk Adults Miss
A systematic review and meta-analysis of over 100,000 children and teenagers with IBD found a significantly increased risk of venous thrombo…
Children with Crohn's or ulcerative colitis face nearly seven times the blood clot risk of healthy kids, yet prevention guidelines for teens…
Apr 14, 2026
Cardiology
Meta-analysis
External validation of three DVT prediction models in 1,270 acute stroke patients
Three DVT prediction models showed varying accuracy in a single-center stroke study
This single-center spatial validation cohort study assessed three deep vein thrombosis (DVT) prediction models in 1,270 patients with acute …
The Lu Qiufang model outperformed others with 82.1% accuracy in predicting deep vein thrombosis among 1,270 acute stroke patients at a Shenz…
Frontiers
Apr 14, 2026
Infectious Disease
Meta-analysis
DOACs reduce thromboembolic events in pediatric patients compared to standard anticoagulation
A Pill Form of Blood Thinner May Be Safer for Kids Than Standard Shots
A meta-analysis of 2,002 pediatric patients found direct oral anticoagulants (DOACs) significantly reduced thromboembolic event recurrence (…
New oral blood thinners cut dangerous blood clot recurrences in half for children without increasing bleeding risks compared to standard sho…
Frontiers
Apr 13, 2026